Article
Marizomib suppresses triple-negative breast cancer via proteasome and oxidative…
medRxiv · 2019 · Prahlad V. Raninga
Key facts
| Title | Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition |
|---|---|
| First author | Prahlad V. Raninga |
| Journal | medRxiv |
| Published | Oct 11, 2019 |
| DOI | 10.1101/801720 |
| Devices mentioned | K895872 |
| Product codes mentioned | DBF |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1